Andrew Daly Selected Research

thymoglobulin

1/2019	Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
1/2018	Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
5/2016	Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts.
1/2016	Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation.
8/2014	High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host disease.
4/2010	The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.
8/2008	Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Daly Research Topics

Disease

20	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 06/2003
6	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 06/2003
5	Infections 01/2020 - 06/2003
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 10/2005
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 01/2016
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2018 - 10/2005
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 01/2018
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2018
2	Neoplasms (Cancer) 12/2020 - 11/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 12/2012
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020
1	Hypertrophy 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2018
1	Hemorrhagic Cystitis 06/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Systemic Scleroderma (Systemic Sclerosis) 01/2017
1	Herpes Zoster 12/2016
1	Postherpetic Neuralgia 12/2016
1	Leukemia 05/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Hematologic Diseases (Blood Diseases) 01/2016
1	Bronchiolitis Obliterans Syndrome 08/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2013
1	Lymphoma (Lymphomas) 05/2012
1	Mycoses (Diseases, Fungus) 06/2003

Drug/Important Bio-Agent (IBA)

9	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 04/2010
7	thymoglobulin FDA Link 01/2019 - 08/2008
6	fludarabineIBA 01/2019 - 10/2005
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2003
5	Busulfan (Busulfex)FDA Link 01/2019 - 04/2010
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2016 - 10/2005
4	Methotrexate (Mexate)FDA LinkGeneric 05/2016 - 05/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 06/2003
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	remestemcel-lIBA 01/2020
1	Dapsone FDA Link 01/2020
1	Atovaquone (Mepron)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2020
1	HydrogelsIBA 01/2019
1	Calcineurin InhibitorsIBA 01/2019
1	oxalylglycineIBA 01/2019
1	Prolyl-Hydroxylase InhibitorsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Valacyclovir (Valtrex)FDA LinkGeneric 12/2016
1	Acyclovir (Aciclovir)FDA LinkGeneric 12/2016
1	Azacitidine (5 Azacytidine)FDA Link 11/2016
1	Complement System Proteins (Complement)IBA 05/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 12/2013
1	Cisplatin (Platino)FDA LinkGeneric 12/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 05/2012
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2005

Therapy/Procedure

23	Cell Transplantation 01/2022 - 01/2016
8	Transplantation 01/2019 - 06/2003
4	Therapeutics 11/2021 - 09/2013
4	Stem Cell Transplantation 06/2017 - 06/2003
3	Homologous Transplantation 12/2020 - 06/2017
3	Hematopoietic Stem Cell Transplantation 01/2020 - 04/2010
2	Drug Therapy (Chemotherapy) 12/2013 - 05/2012
1	Salvage Therapy 12/2013
1	Radiotherapy 05/2012
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2003